The papers reported in the current issue of The American Journal of Digestive Diseases by Morris et al (1) and Stroehlein et al (2) provide new data for our understanding of the application of currently available fecal occult blood tests ( Figure 1 ). There is evidence that fecal testing for occult blood in a prescribed way can provide screening for colon cancer and adenomas (3) . The high incidence of colon cancer in this country which results in approximately 100,000 new cases annually in both men and women should be the catalyst for the wide application of this approach. Only 41% of all detected colorectal cancers are in a localized stage without lymph node involvement at the time of diagnosis, whereas almost all patients in whom colorectal cancer is detected in an asymptomatic stage have localized disease. There is a 30% difference in survival over a ten-year period between the two groups (3). It is obviously important therefore to increase the pe rcentage of colorectal cancers detected in a localized stage without lymph node involvement.
The use of occult blood testing in the stool to provide an earlier diagnosis is not new but, unfortunately, was based primarily on the use of a random stool with the patient on an unmodified diet. This approach resulted in many false positive and false negative reactions. As a result, fecal occult blood testing has generally conveyed a bad impression and has been discarded by most cancer detection centers. There has been a renewed interest in this test since the introduction of the impregnated guaiac slide and stabilized reagent (Hemoccult| The application of this slide test in a prescribed way was popularized by Greegor who recommended use of six slides over a 3-day period, testing two slides per stool specimen on a meat-free, high-bulk diet (4) . In his initial studies there were five positive patients per 100 tested, one of whom had colon cancer, two had diverticulosis, one had an adenoma, and one he considered to be a false positive. His most recent experience suggests that the rate of positive slides is approximately one percent. (5) . This current rate of positive slides agrees with that found by Gnauck (6) and by Winawer et al (7)*. The cancers detected in these series included a greater proportion of earlier lesions than that usually detected in symptomatic patients. When colonoscopy is also used as part of the diagnostic workup of patients with positive slides, a higher proportion of adenomatous polyps and villous adenomas are found (7) .
Questions have been raised about the performance of the test as recommended in an attempt to improve patient compliance. These questions relate to the necessity for a meat-free diet; the necessity for roughage in the diet; investigating patients with weak reactions or only one positive slide; the possible interference of iron, barium, and laxatives; whether 3 slides or 6 slides are necessary; reproducibility; conversion of positive and negative reactions; the relationship of positive tests to hemoglobin concentration in the stool. The two papers reported in the current issue of the Journal (1, 2) address some of these critical questions.
Dietary Meat and False-Positive Reactions
Previous studies left undetermined the true frequency of false positive reactions with Hemoccult, originally felt to be in the range of 1-2% (8) . Both papers in this issue indicate that the rate of false positive reactions may be closer to 10%. There is increasing evidence that this false positivity is probably not related to the meat in the diet, since the previous studies by Ostrow et al showed little decrease in the rate of such tests upon elimination of meat from the diet (8) . It is likely that other peroxidases in the stool account for most of these false positive reactions, and suggests that a better test for occult blood in the stool would be one based upon some property of hemoglobin other than its peroxidase activity. It is clear from Morris Although there is an insignificant reduction in the rate of false positive slides when meat is eliminated, this could still be of some importance in large screening programs involving thousands of people, since any small increment of false positive slides resulting from the peroxidase activity of meat itself would be translated into large numbers of people who would be unnecessarily investigated. In smaller groups, of course, this factor would be of less consequence.
Effects of Iron, Barium, and Laxatives
Morris' studies suggest that barium will not interfere with the performance of the occult blood test. This is important since patients may be given occult blood tests to perform at a time when they may also be undergoing barium studies, although it would seem more logical to perform occult blood testing prior to any decisions for barium radiological workup, Patients undergoing tests for occult blood in the stool often are taking laxatives in preparation for a proctosigmoidoscopy. It is interesting that the laxatives seem to have a beneficial effect on the overall testing, decreasing the number of false positives, and decreasing the number of false negatives. The reduced number of false positives may be a result of dilution of nonhemoglobin peroxidase activities in larger volumes of stool produced by the laxatives. The reduced number of false negatives may be due to the irritant effect of the laxatives, a mechanism similar to that of roughage, as proposed by Greegor (4).
Iron ingestion also seems to reduce the number of false positives and false negatives and, therefore, can be disregarded in the instructions to patients. Neither paper reported on testing with vitamin C for possible interference but there has been some evidence that large amounts of vitamin C may interfere with the Hemoccult slide test, resulting in a false negative result in the presence of significant amounts of blood in the stool (9) .
Conversion of Reactions
An interesting question regarding the Hemoccult slide test is whether reactions that are initially negative or positive can convert. The present study by Morris' group indicates that conversion of a negative reaction to a positive one does not occur with the Hemoccult slide test. In Stroehlein's study, only one in 500 negative reactions were thought to have converted to positive. These results are in sharp contrast to that seen with Hematest and standard guaiac, both of which can convert from negative to positive with high frequency after storage for as little as two days. This occurred to the greatest extent with Hematest, suggesting that this test may be totally unreliable. The poor reproducibility of Hematest was previously demonstrated by Ostrow et al (8) . The opposite conversion from positive to negative may occur with the Hemoccult slide after storage for two days. Our own studies suggest that this may be a significant factor and may be especially important with low concentrations of hemoglobin in the stool. Prompt testing of slides is therefore essential.
Relationship to Hemoglobin Concentration in Stool
Most studies confirm that there is a higher rate of positivity of slide testing with increasing concentrations of hemoglobin in the stool. In addition, both studies support the intermittent character of blood loss in the presence of certain gastrointestinal tract lesions. Both of these observations would strongly suggest that multiple slides must be done over several days in order to obtain a positive reaction on at least one slide in a patient with a bleeding lesion. In Greegor's initial studies, and in our current screening program, six slides are done. The difference in cost between using three slides and six slides is very small. The major cost and effort is in initiating this entire approach. Once having established the proper orientation of staff and patients and having provided the mechanics for the performance of the test, it is easy to test six slides rather than three.
The Single Positive Slide
Evidence presented in the papers in this issue of the Journal suggest that a single positive test warrants investigation. The results in our screening program also support this position, since patients with a single positive test have had significant colon lesions, including cancers and large adenomas. The question of the disposition of a trace reaction was raised in both papers. These papers, as well as the experience of Greegor and others, and our experience indicate that reactions that do not produce a blue color should not be considered trace but should be considered negative and discarded. Reactions that produce a blue color regardless of whether the reaction is weak or strong should be considered positive and the patient investigated. Inclusion of reactions other than blue will result in an increased number of false positives and elimination of the weak bIue reactions will produce an increase in the false negatives.
False Negative Results
All of the currently used tests result in false negatives in the presence of blood in the stool. Both studies in the current issue suggest that this may result from low concentrations of hemoglobin in the stool and intermittency of the bleeding from a lesion. False negatives may also result when reactions that are initially positive revert to negative during the interval between sampling and testing. According to our observations and the observations of Go and colleagues (10) this is especially true with low concentrations of hemoglobin in the stool. False negatives have been documented in the clinical application of this approach. Some patients with lesions found on proctosigmoidoscopy have been negative by Hemoccult slide testing. These have been primarily patients with benign polyps of varying size. False negatives do not detract from the significant case-finding potential of this test. In assessing the false negative rate in both papers in this issue, one must bear in mind that there were no dietary restrictions in either study and no encouragement of roughage in the diet. False negative reactions may result from absence of significant amounts of blood in the stool in the presence of a colonic lesion even with use of dietary roughage. The presence of false negatives is not unexpected and should alert us to the use of additional methods in screening that are currently available, such as proctosigmoidoscopy and other methods that may become available in the future.
CONCLUSION
The papers reported in this issue are important contributions to our understanding of the currently used fecal occult blood test. On the basis of the evidence presented, a rational approach would be to test multiple stools with a minimum of six slides, as originally suggested by Greegor, followed by investigation of patients with a single positive slide. The importance of a meat-free diet has been questioned, but for the present it may still be advisable to eliminate meat in any large screening program, since even a small increase in the false positivity resulting from this would be magnified many times over, resuiting in unnecessary gastrointestinal investigations. However, it is possible that elimination of the meat-free rule may improve patient compliance for the test. This remains to be demonstrated. The use of roughage was clearly established in the initial work of Greegor and was not further studied in these reports. Hematest and the standard guaiac solution should be discarded from fecal occult blood testing for colon cancer. It seems that iron can be disregarded as an interfering substance and that laxatives provide a beneficial result in the testing. On the basis of an earlier report, it would seem that vitamin C has potential for producing a false negative result and should be excluded during the testing period. Since initially positive results can revert to negative, especially with low concentrations of hemoglobin in the stool, it is important that patients do their tests immediately prior to coming in for examination and that the slides be personally brought in rather than mailed and that the test be done promptly.
It is discouraging that, although millions of Hemoccult slides are currently in use in this country annually, few are being used in the manner prescribed by Greegor. If we are to obtain a higher percentage of colon cancers from coming to surgery at an earlier pathological stage and also identify patients with premalignant colonic adenomas, we will have to assume a positive attitude with our patients in a preventive screening approach. In our own program, patient compliance for the screening and for further gastrointestinal investigation has been very high when the patients are presented with such an approach. It remains to be seen what the compliance will be in less-motivated populations. In such a program, the rate of positive results, which runs about one percent, is manageable in, terms of further workup, and abnormalities are found in the majority of positive patients. The low rate of false positives and false negatives do not detract from this method when one considers the case finding produced by this approach (4,@ 7, 11, 12) . In working up these patients, an aggressive diagnostic program is needed to uncover all colonic abnormalities, including good barium enemas after proper cleansing, and preferably with the addition of air- The value of this test is primarily in the asymptomatic patient at risk for colon cancer who does not have an independent underlying source of bleeding, such as one of the polyposis syndromes or inflammatory bowel disease, since these diseases can result in stools positive for occult blood without the superimposition of carcinoma. We can expect a higher rate of detection of adenomas than colon cancer in the population at risk, Previous experience by Gilbertsen (13) suggests strongly that identification of asymptomatic patients with colonic adenomas and removal of these adenomas could result in a lower incidence of colonic cancer in this population, providing that the colon is completely cleared of all synchronous lesions. He has shown this in a long-term study on utilizing sigmoidoscopy. The same improvement in incidence of colon cancer should result by utilization of currently available screening methods, including the fecal occult blood test followed by aggressive workup of patients who are positive. This entire approach will not be successful unless there is increased public awareness and a reorientation of the practice of medicine towards a more preventive approach.
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